ADCY10

Chr 1AD

adenylate cyclase 10

Also known as: HCA2, HEL-S-7a, SAC, SACI, Sacy, hsAC

The protein encoded by this gene belongs to a distinct class of adenylyl cyclases that is soluble and insensitive to G protein or forskolin regulation. Activity of this protein is regulated by bicarbonate. Variation at this gene has been observed in patients with absorptive hypercalciuria. Alternatively spliced transcript variants encoding different isoforms have been observed. There is a pseudogene of this gene on chromosome 6. [provided by RefSeq, Jul 2014]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 1.031 OMIM phenotype
Clinical SummaryADCY10
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
36 unique Pathogenic / Likely Pathogenic· 325 VUS of 698 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.03LOEUF
pLI 0.000
Z-score 1.29
OE 0.85 (0.701.03)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.46Z-score
OE missense 0.96 (0.901.01)
788 obs / 824.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.85 (0.701.03)
00.351.4
Missense OE?0.96 (0.901.01)
00.61.4
Synonymous OE?1.03
01.21.6
LoF obs/exp: 69 / 81.5Missense obs/exp: 788 / 824.8Syn Z: -0.38

This gene — mechanism propensity

DN
0.6551th %ile
GOF
0.6444th %ile
LOF
0.3453th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

698 submitted variants in ClinVar

Classification Summary

Pathogenic22
Likely Pathogenic14
VUS325
Likely Benign182
Benign121
Conflicting12
22
Pathogenic
14
Likely Pathogenic
325
VUS
182
Likely Benign
121
Benign
12
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
20
0
2
0
22
Likely Pathogenic
14
0
0
0
14
VUS
4
305
13
3
325
Likely Benign
0
30
66
86
182
Benign
0
6
105
10
121
Conflicting
12
Total3834118699676

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

18 pathogenic / likely-pathogenic (of 23) ClinVar copy-number / structural variants overlap ADCY10 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ADCY10 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →